Clinical Trial

A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder

Name: A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder — clinical trial record (NCT07193563)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 2

View on ClinicalTrials.gov →

Summary

This is a double-blind study to evaluate the efficacy and safety of ENX-102 in participants with social anxiety disorder (SAD).

Protocol Amendment History 1 change

critical Trial completed 2026-04-09

Trial Details

NCT Number	NCT07193563
Lead Sponsor	Engrail Therapeutics INC
Conditions	Social Anxiety Disorder (SAD)
Enrollment	47 participants
Start Date	2025-09-05
Primary Completion	2026-03-19 (estimated)
Study Completion	2026-03-19 (estimated)
Updated on ClinicalTrials.gov	2026-04-08